Eloxx Pharmaceuticals Enhances Financial Stability with $66 Million Offering and Nasdaq Uplisting#USA#Arlington#Eloxx_Pharmaceuticals#Nonsense_Mutations#Exaluren
Eloxx Pharmaceuticals Enhances Financial Stability with $66 Million Offering and Nasdaq Uplisting
Eloxx Pharmaceuticals has reported a significant financial boost with a recent public offering and Nasdaq uplisting, facilitating clinical progress in kidney disease treatments.
third-news.com
August 12, 2026 at 10:14 AM
Eloxx Pharmaceuticals Enhances Financial Stability with $66 Million Offering and Nasdaq Uplisting#USA#Arlington#Eloxx_Pharmaceuticals#Nonsense_Mutations#Exaluren